| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.086 | 21.341 | 15.797 | 21.758 | 17.134 | 25.787 | 33.994 | 38.047 | 41.622 | 42.492 |
| Total Income - EUR | 23.094 | 21.350 | 15.816 | 21.765 | 17.153 | 25.808 | 34.020 | 38.078 | 41.628 | 42.494 |
| Total Expenses - EUR | 3.188 | 1.834 | 3.898 | 6.504 | 8.497 | 14.717 | 15.464 | 19.315 | 20.482 | 25.898 |
| Gross Profit/Loss - EUR | 19.907 | 19.515 | 11.919 | 15.261 | 8.656 | 11.091 | 18.556 | 18.763 | 21.145 | 16.596 |
| Net Profit/Loss - EUR | 19.214 | 18.875 | 11.476 | 15.043 | 8.484 | 10.858 | 18.398 | 18.390 | 20.737 | 16.180 |
| Employees | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Eresmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 35.743 | 22.184 | 33.627 | 33.030 | 37.702 | 41.186 | 58.554 | 43.062 | 31.952 | 17.830 |
| Inventories | 0 | 69 | 0 | 136 | 396 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 54 | 2 | 0 | 3.443 | 2.909 | 5.004 | 11.806 | 23.927 | 26.829 | 13.717 |
| Cash | 35.690 | 22.114 | 33.627 | 29.451 | 34.396 | 36.181 | 46.748 | 19.135 | 5.123 | 4.114 |
| Shareholders Funds | 35.259 | 22.119 | 33.221 | 31.820 | 37.447 | 38.891 | 56.427 | 18.556 | 20.903 | 4.310 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 484 | 65 | 405 | 1.209 | 254 | 2.295 | 2.127 | 24.506 | 11.049 | 13.520 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Eresmed S.r.l.